For The Consortium

Building Connections

CTSA Connection Opportunities
NIH Connection Opportunities

CTSA Connection Opportunities

Principal Investigator Profiles

Each CTSA is led by a principal investigator, an established clinician scientist, who has the primary responsibility to define objectives and approaches of the CTSA.

Click for a listing of the 2011 only CTSA principal investigator profiles.
Click for a complete listing of CTSA principal investigator profiles.

Liaisons with the NIH Institutes and Centers

Principal investigators from the CTSA institutions have been designated to serve as liaisons to the NIH Institutes and Centers in order to:
  • Establish lines of communications
  • Increase awareness of CTSA resources available for IC funded researchers
  • Improve the efficiency of all aspects of clinical and translational science
  • Maximize the trans-NIH investment in core resources

Click for a listing of CTSA liaisons to the NIH Institutes & Centers.

Public-Private Partnerships—Interested in collaboration with the CTSA?

One of the goals of the CTSA consortium is to stimulate alliances in medical research and research training by identifying opportunities for collaboration among CTSA members and private-sector organizations.

View more information.

CTSA Interactions with Business Schools

The CTSA grantees are interacting with business schools and utilizing business principles to enhance translational efforts.

Click for examples of how these interactions are working.

NIH Connection Opportunities

NCRR-Funded Comparative Medicine Resource Center Connects with CTSAs

The Rat Resource and Research Center at the University of Missouri, funded by NCRR's Division of Comparative Medicine and led by Drs. John Critser and Lela Riley, has forged a relationship with several CTSAs to provide a valuable resource and to further drug discovery/drug development in the CTSA consortium.

View more information.

NIH Clinical Center FY 2012 Bench-to-Bedside Awards

New cycle announced – letters of intent are due September 28th, 2011

The NIH Bench-to-Bedside Program is soliciting proposals for the next funding cycle.

Once again, CTSAs, AIAMC (Alliance for Independent Academic Medical Centers) and NIH investigators will be able to initiate applications jointly for Bench-to-Bedside research projects. Up to $135K per year for two years is available to support these intramural/extramural partnerships in clinical research. As in prior years, intramural investigators in all Institutes/Centers are eligible to serve as project leaders on proposals.

Extramural principal investigators (PIs) with an existing NIH grant are invited to initiate proposals in one of two ways:

  • Extramural investigators may seek an intramural partner at NIH who would function as the project leader and serve as the point of contact. To identify an intramural collaborator, extramural investigators can consult the NIH's intramural research database. Extramural investigators also may contact the Bench-to-Bedside Program Office for assistance in identifying an intramural partner.
  • Extramural investigators may initiate proposals and serve as project leaders. In this role, extramural principal investigators will develop letters of intent and, if approved, may develop full proposals. In this scenario, extramural investigators are required to identify an intramural collaborator on the project. On behalf of the lead extramural PI, the intramural investigator will be responsible for submitting both the letter of intent and full proposal electronically using proposalCentral.

For the 2012 awards, a letter of intent must be submitted by September 28, 2011.

The NIH Bench-to-Bedside program was originally established in 1999 to integrate the work of basic and clinical intramural scientists. Since 2006, it has been open to partnerships between intramural and extramural programs.

For additional information, visit the Bench-to-Bedside Program website or contact

NIH Clinical Center Launches Sabbatical in Clinical Research Management

The NIH Clinical Center has launched a Sabbatical in Clinical Research Management pilot program offering clinical investigators, health-care managers and administrators, and others who oversee clinical trials an opportunity to study at the National Institutes of Health.

Participants will learn from other seasoned professionals at the NIH Clinical Center and will have opportunities for electives at other NIH Institutes & Centers, as well as other Federal agencies, such as the Food and Drug Administration (FDA) and the DHHS Office of Human Subjects Protection (OHRP). The sabbatical presents clinician-scientists and others with the unique chance to receive advanced management training to help ensure that they have the knowledge and skills to develop clinical and translational research programs with safe, ethical, and efficient standards.

Through the sabbatical, participants will undertake flexible and individualized educational experiences in clinical research management, while working and learning with the full complement of clinical research experts. Participants will study for anywhere from two months to one year to accomplish their individual learning goals. The sabbatical includes six core modules, each with a selection of electives. The core modules are:

  • Critical Infrastructure
  • Support Services
  • Legal and Regulatory Infrastructure
  • Communications and Outreach
  • Strategic Management
  • Funding Opportunities
Additional information, including module descriptions, examples of elective courses, candidate selection guidelines and application submission information, is available on the Sabbatical in Clinical Research Management website or contact

Sustaining Careers for Women in Science

Many strategies for sustaining women in careers at academic health institutions can be found in the summary of a recent NIH workshop led by Dr. Barbara Alving, "Women in Biomedical Research: Best Practices for Sustaining Career Success." The NIH Office of Research on Women's Health and the Association of American Medical Colleges provide helpful information, as well.

The CTSAs are committed to supporting a diverse workforce, including sustaining women in biomedical careers. Five of the CTSA principal investigators are women, and approximately half of the clinical and translational trainees are women.